Search

everythinglearnresearchcommunity

for

Search:↓

Adding stromal vascular fraction to platelet-rich plasma injections did not significantly improve hair growth in androgenetic alopecia treatment.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

The Biofield Energy Treated herbal mixture increased hair growth in mice compared to the untreated mixture.

Combining Traditional Chinese Medicine and Western medicine can improve symptoms, hormone levels, and pregnancy outcomes in Polycystic Ovary Syndrome patients, but more research is needed.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

Gene differences may affect baldness treatment response in Korean men.

Anabolic steroid users may face higher risk of severe COVID-19.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Latanoprost can make eyelashes longer, thicker, and darker.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.